Skip to main content
TipRanks
Go Ultimate75% OFF

Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

1,730 Followers

Total Valuation

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $718.89M. The enterprise value is $381.53M.

Market Cap
$718.89M
Enterprise Value
$381.53M

Share Statistics

Sagimet Biosciences, Inc. Class A has 70,341,170 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
70,341,170
Owned by Insiders
4.64%
Owned by Institutions
48.29%

Financial Efficiency

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -51.04%.

Return on Equity (ROE)
-0.46
Return on Assets (ROA)
-0.44
Return on Invested Capital (ROIC)
-51.04%
Return on Capital Employed (ROCE)
-0.51
Revenue Per Employee
0
Profits Per Employee
-3.19M
Employee Count
16
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Sagimet Biosciences, Inc. Class A is -8.59. Sagimet Biosciences, Inc. Class A’s PEG ratio is -0.20.

PE Ratio
-8.59
PS Ratio
0.00
PB Ratio
2.63
Price to FCF
-7.70
Price to Operating Cash Flow
-14.73
PEG Ratio
-0.20

Income Statement

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0 and earned -51.04M in profits. Earnings per share was -1.58.

Revenue
0
Gross Profit
0
Operating Income
-56.89M
Pretax Income
-51.04M
Net Income
-51.04M
EBITDA
-51.04M
Earnings Per Share (EPS)
-1.58

Cash Flow

In the last 12 months, operating cash flow was -43.25M and capital expenditures 0, giving a free cash flow of -43.25M billion.

Operating Cash Flow
-43.25M
Free Cash Flow
-43.25M
Free Cash Flow per Share
-0.69

Dividends & Yields

Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-6.07%
Earnings Yield
-8.44%

Stock Price Statistics

Beta
2.64
52-Week Price Change
32.04%
50-Day Moving Average
9.88
200-Day Moving Average
7.73
Relative Strength Index (RSI)
51.81
Average Volume (3m)
1.25M

Important Dates

Sagimet Biosciences, Inc. Class A upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 17, 2027
Ex-Dividend Date
―

Financial Position

Sagimet Biosciences, Inc. Class A as a current ratio of 22.82, with Debt / Equity ratio of 0.07%

Current Ratio
22.82
Quick Ratio
22.82
Debt to Market Cap
0.00
Net Debt to EBITDA
0.68
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -10.79, with an EV/FCF ratio of -13.96.

EV to Sales
0.00
EV to EBITDA
-10.79
EV to Free Cash Flow
-13.96
EV to Operating Cash Flow
-13.96

Balance Sheet

Sagimet Biosciences, Inc. Class A has $236.40M in cash and marketable securities with $2.02M in debt, giving a net cash position of $234.38M billion.

Cash & Marketable Securities
$236.40M
Total Debt
$2.02M
Net Cash
$234.38M
Net Cash Per Share
$3.33
Tangible Book Value Per Share
$3.88

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Sagimet Biosciences, Inc. Class A is $27.16, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$27.16
Price Target Upside
165.77% Upside
Analyst Consensus
Strong Buy
Analyst Count
13
Revenue Growth Forecast
―
EPS Growth Forecast
33.38%

Scores

Smart Score
7
AI Score
58